Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...21222324252627282930...
CompanyDrug NameStatusIndication Group
AETERNA ZENTARIS Neovastat in Phase IIIAntineoplastic & immunomodulating agents
NeoTherapeutics Neotrofin in Phase IINervous system
GlaxoSmithKline Navelbine and Heceptin accomplished Phase IIAntineoplastic & immunomodulating agents
GlaxoSmithKline Navelbine in Phase IIIAntineoplastic & immunomodulating agents
Schering-Plough Nasonex in Phase IIIRespiratory system
Schering-Plough Nasonex Approved in USARespiratory system
Nastech Nascobal Approved in USAAlimentary tract & metabolism
Questcor Nascobal Approved in USAAlimentary tract & metabolism
Sanofi-aventis Nasacort HFA Approved in USARespiratory system
Forest Laboratories Namenda and donezepil Approved in USANervous system
Forest Laboratories Namenda and donezepil discontinuedNervous system
Neurobiological Technologies Namenda discontinuedNervous system
Nabi Bio Nabi-HB Intravenous Submitted for approval in EU and USAAnti-infectives for systemic use
Genitope MyVax in Phase IIAntineoplastic & immunomodulating agents
Genzyme Myozyme Submitted for approval in USA and EUAlimentary tract & metabolism
Transgene MyoDys accomplished Phase IMusculoskeletal system
Wyeth Mylotarg Submitted for approval in EU and JapanAntineoplastic & immunomodulating agents
Teva Pharmaceutical Mylinax in Phase IIINervous system
Novartis Myfortic Approved in USAAnti-infectives for systemic use
NeuTec Pharma Mycograb in Phase IAntineoplastic & immunomodulating agents
...21222324252627282930...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.